AFMS Partners with GRIFOLS to provide Blood Group Genotyping systems to help determine blood groups in individuals who may not be able to be typed with traditional blood grouping methods due to recent transfusions, autoantibodies, or other limitations.
Blood group genotyping for human erythrocyte antigens overcomes blood grouping limitations by looking directly into the DNA sequence and thereby avoiding any donor cell or patient antibody interference. Additional benefits of blood group genotyping include improved transfusion compatibility and reduced alloimmunization.
A multiplex blood group genotyping family of products based on Luminex technology; including kits for the main allelic variants of red blood cells (ID CORE XT, ID RHD XT), human platelet antigens (ID HPA XT), a positive control for ID CORE XT (ID CORE CONTROL), and an accompanying software (BIDS XT).
Detects 29 polymorphisms determining 37 red blood cell antigens
Detects 6 polymorphisms determining 6 RHD variants and HPA-1
Detects 13 polymorphisms determining 12 HPA systems
2 clones including testing for all allele A and B of all polymorphisms tested in ID CORE XT.
Keep track of activity with BIDS XT's comprehensive database for samples, clinical information, and test results.
Salah Alden Road | Al Zahra District
Riyadh | Kingdom of Saudi Arabia
60001 Riyadh 11545
